On study day 0, mice are sensitized with aliquots of 150 µL of a 5% oxazolone solution epicutaneously on their shaved abdomens. On day 7, the right ear of each mouse is challenged with 3% oxazolone solution (10 µL on the front and 10 µL on the back). Left ears are painted on both sides with an ethanol/acetone mixture.

Disease Parameters/Progression:

Mice develop swelling within 24 to 48 hours of antigen challenge.

Dosing Paradigms:

  • Treatment is administered 15 minutes to 1 hour prior to antigen challenge
  • Route of administration: SC, PO, IP, IV, topical

Clinical Assessment:

Body weights are taken on study days 0, 7, and 8 (prior to termination). Ear caliper measurements are taken on days 7 (baseline) and 8 using a Digitrix II micrometer (Fowler & NSK). On day 8 (24 hours post-antigen challenge), animals are necropsied. Measurement of the DTH reaction can be done grossly by comparing the ear core weight difference between normal versus antigen-injected ears (weight is proportional to edema). A 7-mm disc is collected by cork borer (Fisher Scientific) from the pinna of each ear and weighed.

Histopathological Assessment:

Tissues are examined microscopically by a board certified veterinary pathologist (Dr. Alison Bendele) and scored according to these methods.

Sample Data (Click on image to enlarge):

For more information about Oxazolone Induced Ear Delayed Type Hypersensitivity (Mouse) contact us here.


Chemokines such as IL-8, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1a (MIP-1a), and macrophage migration inhibitory factor (MIF) have been found to be involved in the recruitment of leukocytes to the DTH reaction site. Cytokine inhibitors, such as anti-IL-16, have been shown to minimize the DTH response. Other compounds that effectively inhibit the DTH reaction are dexamethasone (a potent steroid that induces lympholysis) and cyclosporine-A (CsA), which inhibit the action and growth of T-lymphocytes.

Optional Endpoint

  • PK/PD blood collections
  • Cytokine/chemokine analysis via Luminex(R)
  • Other sandwich ELISAs
  • CBC/clinical chemistry analysis
  • Soft tissue collection
  • Histopathologic analysis
  • Immunohistochemistry analysis


  1. Yoshimoto T, Wang CR, Yoneto T, et al. Role of IL-16 in delayed-type hypersensitivity reaction. Blood. 2000;95(9):2869–2874.
  2. Owen J, Punt, J, Stranford S. Kuby Immunology. 7th ed. New York: WH Freeman & Company; 2013. Chapter 15, Inflammation: Allergy and Hypersensitivities.


Related Pages

General Inflammation

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now